Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-01-09 @ 7:29 PM
Study NCT ID:
NCT04643002
Status:
RECRUITING
Last Update Posted:
2025-08-11
First Post:
2020-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
Sponsor:
Sanofi
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Plasma Cell Myeloma Refractory | View |